Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 1413 Results Clear All
Once a godsend, antiretroviral therapy is not what we should settle on. The time has come to finally cure HIV/AIDS.
HIV/AIDS Ott Lab
Developed by Gladstone scientists, HIV-seq could uncover new opportunities for treating HIV.
News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab
A new framework that matches vitamins with genetic diseases helped uncover that high-dose vitamin B3 can dramatically extend survival in mice with NAXD deficiency.
News Release Research (Publication) Rare Diseases Jain Lab
The Scientist—Gladstone Investigator Isha Jain discovered that hypoxic conditions trigger red blood cells to absorb and utilize more glucose, reducing blood sugar and offering a potential therapy to control diabetes.
Gladstone Experts Diabetes Jain Lab
Chemical & Engineering News—Gladstone Investigator Jennifer Doudna, the 2026 Priestley Medalist, shares how she struggled to find her way through school before achieving the greatest feats in science.
Gladstone Experts Doudna Lab
Authority Magazine—As part of a series about business leaders who are shaking things up in their industry, Gladstone President Deepak Srivastava describes how the convergence of AI, stem cell biology, and gene editing means that for the first time, it’s realistic to contemplate cures, not just treatments.
Gladstone Experts Srivastava Lab
Roan has made great strides in understanding how persistent viruses including HIV cause disease and how immunity to viruses shapes human health.
Awards News Release COVID-19 HIV/AIDS Infectious Disease Roan Lab
Reuters—Led by Gladstone Investigator Isha Jain, researchers found that low-oxygen conditions cause red blood cells to act like “glucose sponges,” lowering blood sugar.
Gladstone Experts Diabetes Jain Lab
New study shows red blood cells act as hidden glucose sponges in low-oxygen conditions, explaining why people living at high altitude have lower diabetes rates and pointing toward new treatments.
News Release Research (Publication) Diabetes Jain Lab
Gladstone scientists are developing new AI tools that promise to revolutionize how science is done and lead to new treatments for the most devastating diseases.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
Alisa Dietl brings her international training and clinical perspective to Gladstone, where she works to engineer more effective cancer immunotherapies for solid tumors.
Graduate Students and Postdocs Profile Cancer Pelka Lab
SLAS—Steve Finkbeiner, director of the Center for Systems and Therapeutics, was selected as the recipient of the 2026 Innovation Award by the Society for Laboratory Automation and Screening for his work on AI, robotics, and the thinking microscope.
Gladstone Experts Finkbeiner Lab AI Robotic Microscopy
Three recipients of Gladstone’s Outstanding Mentoring Award share their personal approaches to mentorship and reflect how this passion has shaped their own growth as leaders.
Profile Roan Lab Graduate Students and Postdocs
The New York Times—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, comments on how the 4D Nucleome Project is revealing the way DNA misfolding inside the nucleus can contribute to disease. (Subscription required.)
Gladstone Experts Pollard Lab
The Daily Northwestern—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, explains how the 4D Nucleome Project mapped the genome in 3D to understand how the folding of chromosomes relates to DNA function.
Gladstone Experts Pollard Lab
